Clinical Trial

BONEBRIDGE Bone Conduction Implant in Adults

Study Description

BONEBRIDGE Bone Conduction Implant in Adults

Approximately thirty subjects with mixed or conductive hearing loss, meeting FDAa??cleared candidacy criteria for the BONEBRIDGE, will be implanted and followed for three (3) months posta??activation to assess safety and effectiveness of the BONEBRIDGE implant.

Location

Locations Selected Location

Methods

No pharmaceutical medication involved No pharmaceutical medication involved
Recruiting patients only Recruiting patients only

Device - BONEBRIDGE

Bone Conduction Implant

Additional Information

Official Study Title

Outcomes in Adults With Mixed or Conductive Hearing Loss Implanted With the BONEBRIDGE

Clinical Trial ID

NCT03859648

ParticipAid ID

eZ6G2e